
Related Companies
NSE
BSE
ICICI Securities has given a add rating to Dr. Lal Pathlabs with a target price of Rs 2430. The share price moved up by 3.25 per cent from its previous close of Rs 2196.20. The stock’s last traded price is Rs 2267.65.
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18504.65 Crore) operating in Hospitals & Allied Services sector.
Financials
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 431.90 Crore, up 62.37 % from last quarter Sales of Rs 266.00 Crore and up 18.13 % from last year same quarter Sales of Rs 365.60 Crore Company reported net profit after tax of Rs 87.10 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 56.3 per cent stake in the company as of Sept 30, 2020, while FIIs held 24.2 per cent, DIIs 7.8 per cent and public and other 12.7 per cent.
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18504.65 Crore) operating in Hospitals & Allied Services sector.
Financials
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 431.90 Crore, up 62.37 % from last quarter Sales of Rs 266.00 Crore and up 18.13 % from last year same quarter Sales of Rs 365.60 Crore Company reported net profit after tax of Rs 87.10 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 56.3 per cent stake in the company as of Sept 30, 2020, while FIIs held 24.2 per cent, DIIs 7.8 per cent and public and other 12.7 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.